Delivery Order SPE2DX22D0010-SPE2D825FEC16
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,962.78, is for the delivery of AZSTARYS CAPS 52.3MG/10.4MG medical supplies. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
- This is a $1,150.76 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract is for the supply of the pharmaceutical product AZSTARYS 39.2 MG-7.8 MG CAP 100S. The contract was awarded on July 19, 2024 and has a completion date of July 22, 2024. The contract is a Firm Fixed Price type and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, leverages its extensive supply...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, valued at $4,893.00, is a Firm Fixed Price Delivery Order contract for the pharmaceutical product AZSTARYS 26.1 MG-5.2 MG CAP 100S. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of AZSTARYS CAPS 39.2MG/7.8MG medical products, with a firm fixed price and a ceiling value of $6,592.08. The contract has an ultimate completion date of July 16, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal...
- AmerisourceBergen Drug Corp has been awarded a delivery order for AZSTARYS Capsules (39.2mg/7.8mg) valued at $1,567.95 by the Defense Department's Medical Supply Chain division. This competitively awarded, non-set-aside contract is priced on a firm fixed-price basis with a completion date of June 3, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations as a major healthcare...
- The Defense Logistics Agency Medical Supply Chain awarded a $6,044 delivery order to AmerisourceBergen Drug Corp for AZSTARYS CAPS 39.2MG/7.8MG on October 16, 2025, with an ultimate completion date of October 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a continuation of the critical pharmaceutical supply relationship between the federal government and AmerisourceBergen, one of the nation's largest pharmaceutical distributors. The...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a prescription medication. The contract has a ceiling value of $1,156.16 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,724.87 to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Azstarys Caps 39.2mg/7.8mg, a pharmaceutical product. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 11, 2025, and performance will occur at the contractor's facility in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order leverages AmerisourceBergen's...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ07S, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.37 firm fixed price delivery order is for the supply of AZSTARYS 52.3 MG-10.4 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award, with an ID of SPE2DB20D3101|SPE2DB25FREJ6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $1,613.20 and an ultimate completion date of March 14, 2025. The contract covers the procurement of AZSTARYS 52.3 MG-10.4 MG CAP 100S, a pharmaceutical product. This award is...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FEC16Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,284.14, is for the delivery of AZSTARYS CAPS 39.2MG/7.8MG, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 12, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and this award is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 3/11/25 |